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Abstract
Background and Purpose: The study compared characteristics and outcomes in patients with solitary and
bilateral kidneys who were treated with percutaneous nephrolithotomy (PCNL) in the Clinical Research Office
of the Endourological Society (CROES) PCNL Global Study.
Patients and Methods: Data from consecutively treated patients from 96 centers worldwide were collated after a
1-year period. The following variables in patients undergoing PCNL with solitary or bilateral kidneys were
compared: Prevalence, patient characteristics, intraoperative differences and outcomes, including bleeding and
transfusion rates, renal function, and stone-free rates.
Results: Data from 5803 patients were collated; 189 (3.3%) with solitary and 5556 (96.7%) with bilateral kidneys.
Patient characteristics were well matched generally with the exception of cardiovascular disease and American
Society of Anesthesiologists (ASA) risk scores, which were significantly greater in patients with solitary than
with bilateral kidneys (P < 0.0001 and P = 0.004, respectively). Patients with solitary kidneys had also undergone
significantly more procedures to remove calculi before this survey than bilateral patients (P = 00.049 - < 0.0001).
Levels of renal impairment were significantly greater (P < 0.0001) and stone-free rates were significantly lower
(P = 0.001) post-PCNL in solitary than bilateral kidney patients. Although bleeding rates were the same in both
groups, transfusion rates were significantly greater in solitary kidney patients (P = 0.014).
Conclusions: Patients with a solitary kidney had a higher cardiovascular risk and ASA score. Outcomes related
to morbidity and stone-free rate were less favorable for solitary kidneys.
Introduction
Renal agenesis and renal dysplasia are commonlyoccurring renal congenital anomalies that produce the
condition of solitary kidney. While the prevalence of con-
genital solitary kidney is unknown because it is often
asymptomatic, it is estimated by autopsy that 1 in 1000 per-
sons may have been born with just a single kidney, although
ultrasonographic scanning suggests this frequency may be
higher at 1 in 500 of the general population.1,2 Congenital
malformations, however, are not the sole cause. Unilateral
nephrectomy after trauma, cancer or nephrolithiasis or sec-
ondary to the complications of nephrolithiasis and its treat-
ment also contributes to the number of persons with solitary
kidneys as does increasing kidney donation.2 Subsequently,
solitary kidneys may be more common than currently esti-
mated.
The presence of kidney stones in persons with bilateral
kidneys is known to have detrimental effects and, if not
promptly treated, may cause renal insufficiency and eventu-
ally renal failure.3 The frequency of renal insufficiency in
patients with kidney stones is highly variable, but in one
study, 6.3% of patients had a serum creatinine level of
> 1.5 mg/dL, and rates of renal insufficiency between 0.78% to
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17.5% have been reported from a variety of other centers.3
Furthermore, duration of nephrolithiasis, its recurrence, and
its treatment with multiple procedures also has a negative
effect on renal function.4
While it was known that stone removal was beneficial, be-
fore the introduction of percutaneous nephrolithotomy
(PCNL), concerns were expressed about the effects of the
procedure on kidney function and associated complications,
particularly in patients with solitary kidneys. The technique of
PCNL has been practiced for more than 30 years and has
constantly undergone refinements. It is currently the preferred
first-line therapy for renal stones that are not amenable to
extracorporeal shockwave lithotripsy (SWL) or ureteroscopy
(URS), such as large volume and staghorn calculi.5 PCNL is
not known to cause significant functional nephron damage,
and many patients with renal impairment experience im-
provement in renal function post-PCNL.6–8 Nevertheless, the
management of calculi with PCNL remains challenging, par-
ticularly in those patients with solitary kidneys.
The Clinical Research Office of the Endourological Society
(CROES) instigated the PCNL Global Study to generate a
global database on the utility of the technique as assessed
primarily by stone-free rate 30 days post-PCNL, but also
through assessment of morbidity and other factors influenc-
ing outcomes.9 The current analysis compares outcomes in
patients who present with solitary or bilateral kidneys.
Patients and Methods
The CROES PNCL Global Study organization and methods
have been described in detail elsewhere.10 The study is a
prospective observational study of consecutive patients who
were treated at each participating center over the course of a
single year. Overall, data were gathered from 96 centers
worldwide. Patients who were eligible for inclusion had un-
dergone PCNL for primary or secondary treatment of kidney
stones; there were no specific exclusion criteria. Local guide-
lines and practices for PCNL procedures were followed.
Ultrasonography and/or radiography in combination with
fluoroscopy guided upper tract access. Thereafter, and after
caliceal puncture of the collecting system, a guidewire was
inserted and maneuvered toward the ureter. Dilation of the
tract to allow positioning of an access sheath and passage of a
rigid nephroscope was attained with either balloon, telescopic,
or serial dilators. After nephroscopic inspection, complete
stones were removed using graspers or, if needed, lithotripsy
by laser, ultrasound, or ballistic means was undertaken to
fragment larger stones. The procedure was considered com-
plete when all removable stones had been extracted. Stone-free
status was determined at 30 days using a choice of radiogra-
phy at the discretion of the treating physician. Bleeding se-
verity was judged by the treating physician, and transfusions
were administered according to local practice guidelines.
Within the database of patients who were treated with
PCNL, we identified those with a solitary kidney, identified on
the basis of upper tract imaging studies including ultraso-
nography, intravenous urography, or cross-sectional imaging.
Data analysis
Patients were classified depending on the presence or ab-
sence of anomalies into those with solitary or bilateral kid-
neys. Data on a number of variables, including patient
characteristics, intraoperative differences, including puncture
site, access location, method of guidance and dilation, and
outcomes, including bleeding rates, operative time, pre- and
postoperative serum creatinine concentrations, were ana-
lyzed to compare differences between groups.
SPSS version 16.0 was used to analyze the collected data.
All data are descriptive and based on frequencies. Continuous
variables were analyzed using the Mann-Whitney U test
while the Pearson chi-square test was used for comparison of
categorical variables.
Results
A total of 5803 patients were included in the CROES da-
tabase during the period between November 2007 and De-
cember 2009. Of these, 58 patients were excluded from the
analysis, because information on whether they had solitary
kidneys was not recorded. Of the remaining 5745 patients, 189
(3.3%) had solitary and 5556 (96.7%) had bilateral kidneys.
Patient characteristics
Patient characteristics according to kidney status are
shown in Table 1. Data on origin of the solitary kidney were
unknown and might have been from congenital, traumatic,
oncologic, nonfunctional, or donation causes. The proportion
of males to females in each group was broadly similar. The
mean age of those with solitary kidneys was, however,
slightly higher, although not significantly so. Both groups had
similar proportions of patients with diabetes, and median
body mass index (BMI) was also well matched. A significantly
greater proportion of patients with solitary kidneys had car-
diovascular disease, however, as reflected in the significantly
greater proportion with American Society of Anesthesiolo-
gists (ASA) scores of 2 to 4 (P = 0.004). A greater proportion
of patients with solitary kidneys used anticoagulants and
corticosteroids, although statistically significant differences
between groups in use of these drugs were not noted.
Considering previous procedures, patients with solitary
kidneys had undergone PCNL (P = 0.049), pyelolithotomy,
and nephrostomy (P < 0.0001) significantly more frequently
than those patients with bilateral kidneys; there were no sig-
nificant differences in proportions of patients having under-
gone previous SWL or URS. No significant differences in
median stone burden, positive preoperative urine cultures, or
in the proportion of patients with staghorn stones were ob-
served between groups.
Intraoperative procedures
Details of the intraoperative procedures used, including
guidance and dilation techniques, and access and renal
puncture sites in each of the patients groups, are shown in
Table 2. Overall, no statistically significant differences be-
tween groups were observed. Generally, patients in both
groups had a greater proportion of lower and middle punc-
tures than upper kidney punctures, although a slightly
greater proportion of patients with solitary kidneys than with
bilateral kidneys had middle punctures and slightly more
bilateral kidney patients experienced lower renal punctures.
Cutaneous access in both groups was most frequently made
below the 12th rib. The ratio of balloon to telescopic/serial
dilation was broadly similar between groups.
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Outcomes
The principal postoperative outcomes are shown in Table 3.
Stone-free rates were significantly lower (P = 0.001) and the
need for blood transfusion was significantly higher (P = 0.014)
in patients with solitary kidneys compared with those with
bilateral kidneys. Mean preoperative and first day postoper-
ative serum creatinine concentrations were significantly
higher in the solitary kidney group (P < 0.0001; Fig. 1); in both
groups, serum creatinine concentrations were elevated on the
first day postoperatively compared with preoperative values.
Similar results were reported in both groups of patients con-
cerning percentage of failed procedures and the occurrence of
hydrothorax, perforation, and fever.
Discussion
As part of an ongoing series of CROES PCNL Global Study
analyses, the article presented here compares outcomes in pa-
tients with solitary vs bilateral kidneys. The 3.3% rate of PCNL
procedures in patients with solitary kidneys identified in the
CROES database might be thought to be relatively low until the
estimated occurrence of solitary kidney within the general
population is considered. If the frequency of solitary kidney as
estimated by ultrasonography is 1 in 500, this equates to a
population frequency of congenital solitary kidney of approx-
imately 0.002%.2 Even taking into consideration the likely in-
cidence of solitary kidney from other causes, the frequency of
solitary kidney noted in this survey suggests that kidney stones
are diagnosed or occur more frequently in patients with soli-
tary kidneys than in patients with bilateral kidneys.
That kidney stones are being diagnosed more frequently in
patients with solitary kidneys (possibly through more diligent
monitoring by the physician) is supported by the observation
of the statistically significantly increased occurrence of pre-
vious PCNL, pyelolithotomy, and nephrostomy procedures
noted in patients with solitary compared with bilateral kid-
neys. Clearly, it is important to remove obstructions and re-
instate drainage of urine promptly in patients with solitary
kidney to prevent further injury to a sole functioning kidney.
Whether a greater proportion of patients with solitary kidneys
experience more severe renal blockages associated with
Table 1. Patient Characteristics
Patient characteristic Solitary kidney Bilateral kidneys P value
Sex (male/female) 58.7/41.3 56.4/43.6 0.568
Mean (SD) age (years) 51.6 (15) 49.1 (16) 0.055
Median (IQR) BMI 27.0 (24–30) 26.7 (23–29) 0.227
Proportion of patients, N (%)
With diabetes 24 (12.8%) 748 (13.5%) 0.872
Using anticoagulants 14 (7.5%) 300 (5.4%) 0.289
Using prednisolone 5 (2.7%) 64 (1.2%) 0.126
With CVD 66 (35.1%) 1262 (22.8%) < 0.0001
Positive urine culture 34 (18.6%) 847 (15.8%) 0.364
With staghorn stones 46 (26.4%) 1404 (27.4%) 0.855
Proportion of patients having undergone previous procedures, N (%)
PCNL 37 (19.6%) 781(14.2%) 0.049
SWL 40 (21.3%) 1172 (21.2%) 0.990
Pyelolithotomy 33 (17.7%) 429 (7.8%) < 0.0001
URS 22 (11.8%) 536 (9.7%) 0.425
Nephrostomy 46 (24.5%) 388 (7.1%) < 0.0001
Proportion of patients with systemic disease assessed
according to ASA assessment scale (%) 0.004
ASA grade 1 76 (41.8%) 2929 (53.6%)
ASA grade 2 74 (40.7%) 1909 (34.9%)
ASA grade 3 28 (15.4%) 587 (10.7%)
ASA grade 4 4 (2.2%) 47 (0.9%)
Median (IQR) stone burden (mm2) 347.00 (110–630) 314.00 (130–550) 0.110
SD = standard deviation; IQR = interquartile range; BMI = body mass index; CVD = cardiovascular disease; PCNL = percutaneous
nephrolithotomy; SWL = shockwave lithotripsy; URS = ureteroscopy; ASA = American Society of Anesthesiologists.









Puncture site (%) 0.079
Upper 17 (9.0%) 556 (10.1%)
Middle 41 (21.7%) 874 (15.8%)
Lower 111 (58.7%) 3653 (66.2%)
Multiple 20 (10.6%) 439 (8.0%)
Location of access (%) 0.757
Above 11th rib 4 (2.1%) 80 (1.5%)
Above 12th rib 27 (14.4%) 829 (15.3%)
Below 12th rib 156 (83.4%) 4526 (83.3%)
Guidance (%) 0.924
US 21 (11.2%) 567 (10.4%)
Fluoroscopy 121 (64.7%) 3455 (63.6%)
Fluoroscopy + US 25 (13.4%) 819 (15.0%)
Other 20 (10.7%) 591 (10.9%)
Dilation method (%) 0.622
Balloon 72 (39.1%) 2174 (40.9%)
Telescopic dilators 112 (60.9%) 3135 (59.1%)
US = ultrasonography.
338 BUCURAS ET AL.
kidney stones remains questionable, however, because no
significant difference in the frequency of staghorn stones was
noted between groups.
No statistically significant difference in the ratio of males to
females was noted between groups. It is believed that con-
genital renal agenesis affects approximately twice as many
males as females.1 If this is the case, and if the majority of
patients who were identified by CROES have congenital renal
agenesis, one might have expected the ratio of males to fe-
males in the solitary kidneys group to be skewed toward a
much greater proportion of affected males than that seen.
Such was not the case, however, suggesting that other rea-
sons, such as a greater loss of kidneys to trauma or cancer
occurs more frequently in females, may ‘‘balance’’ the gender
ratio. Without knowing the underlying origins of solitary
kidneys in our cohort, however, such suggestions must re-
main speculative.
A greater proportion of patients with solitary kidneys than
bilateral kidneys had cardiovascular disease (CVD). There was
no difference, however, in the frequency of diabetes or in
median BMI between the groups, suggesting that the in-
creased frequency of CVD noted in the solitary kidneys group
was because of more than the usual cardiovascular risk factors.
Similarly, ASA risk scores were also greater in patients with
solitary than bilateral kidneys, suggesting that solitary kidney
patients are more likely to have serious systemic disease.
Are patients with solitary kidneys at higher risk of systemic
and CVD than those with bilateral kidneys because of their
functional renal impairment? It has been observed that over
time, kidney function decreases in children with a solitary,
functional kidney.11 This may be despite, or possible because
of the mechanisms, such as glomerular hypertrophy, that
often come into play to compensate for loss of renal mass.
Serum creatinine levels are raised compared with controls,
indicating that renal function is impaired.12 The level of renal
impairment, however, may be slight and can remain stable for
many years; only in later life might serum creatinine levels
indicative of true renal impairment become apparent.
With regard to outcomes, in the current analysis of the
PCNL Global Study, significant differences in median pre-
operative and pos-operative serum creatinine concentrations
were noted between groups. That serum creatinine levels
were higher and, therefore, that renal function was impaired
Table 3. Outcome after Percutaneous Nephrolithotomy
Outcome measure Mono kidney Bilateral kidneys P value
Median (IQR) operative time (min) 75.0 (55–120) 75.0 (50–110) 0.173
No. (%) stone free 123 (65.4%) 4189 (76.1%) 0.001
Re-treatment methods
No. (%) URS 1/31 (3.2%) 79/842 (9.3%)
No. (%) PCNL 16/31 (51.6%) 372/842 (44.2%)
No. (%) SWL 11/31 (35.4%) 342/842 (40.6%)
No. (%) Other 3/31 (9.6%) 48/842 (5.7%)
No. (%) bleeding 19 (10.2%) 424 (7.7%) 0.280
No. (%) blood transfusions 19 (10.1%) 306 (5.6%) 0.014
No. (%) blood transfusions among
balloon dilated
5 (6.9%) 148 (7.0%) 0.997
No. (%) blood transfusions among
telescopic dilated
14 (12.6%) 114 (4.6%) < 0.0001
Mean (SD) preoperative serum
creatinine concentration (mg/dL)
1.4 (0.74) 1.0 (0.43) < 0.0001
Mean (SD) first day postoperative
serum creatinine concentration (mg/dL)
1.5 (0.8) 1.1 (0.43) < 0.0001
No. (%) fever 25 (13.3%) 570 (10.4%) 0.242
No. (%) perforations 8 (4.3%) 180 (3.3%) 0.573
No. (%) hydrothorax 2 (1.1%) 102 (1.9%) 0.434
No. (%) failed procedures 2 (1.1%) 97 (1.8%) 0.471
IQR = interquartile range; URS = ureteroscopy; PCNL = percutaneous nephrolithotomy; SWL = shockwave lithotripsy; SD = standard
deviation.
FIG. 1. Serum creatinine levels pre- and postpercutaneous
nephrolithotomy in patients with a solitary kidney or bilat-
eral kidneys.
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in those patients with solitary kidneys was not unexpected.
Renal compensatory hypertrophy was likely the cause of this
observation, although it should be noted that the median
preoperative value of serum creatinine in the solitary kidney
patients is indicative of mild to moderately impaired renal
function. That mean serum creatinine values in both patient
groups were elevated on the first postoperative day and
therefore that renal function was further slightly impaired
was also to be expected and has been observed elsewhere.13,14
In these reports, serum creatinine levels returned to normal
within 2 weeks and, while data were not available, it is an-
ticipated that this would also be the case in the patients re-
ported here.
Bleeding during and after PCNL continues to be a cause of
patient morbidity. While no significant differences in the oc-
currence of bleeding was noted between groups, the need for
transfusion was almost doubled in solitary kidney compared
with bilateral kidney patients. One explanation for this could be
that slightly more patients with solitary kidneys were using
anticoagulants and, therefore, the bleeding might be more dif-
ficult to staunch. Hypertrophy of the kidney is also a recognized
risk for excessive bleeding, which could further contribute to the
increased transfusion requirement in solitary kidney patients.15
More importantly, the condition of a higher ASA score and
CVD may be an important factor to decide, even at lower
threshold, for blood transfusion. Also stone size, upper caliceal
puncture, multiple punctures, staghorn stones, and inexperi-
enced surgeon are risk factors for hemorrhage post-PCNL.15,16
Because PNCL is the most complicated stone treatment to teach,
the importance of the risk associated with the inexperienced
surgeon in PCNL should never be underestimated.17
Stone removal in solitary kidney patients needs to strike a
balance between aggressive clearance and safety, and it may
be that the balance reflected in our cohort is not yet optimal.
The significantly lower stone-free rate noted in solitary
compared with bilateral kidneys patients suggests that
urologists were being cautious in the approaches being
taken with stone removal, possibly resulting in less rigorous
removal of stone fragments to avoid bleeding and any
damage that might compromise renal function. In PCNL,
surgical bleeding is the main cause of blood loss. Optimizing
renal access, tract dilation, and renal manipulation while
minimizing technical error in addition to an awareness of
stone size during extraction, minimal nephroscope angula-
tion, and the exertion of minimal torque forces on the kidney
during PCNL all serve to reduce intraoperative bleeding and
therefore the need for transfusion.18
Nevertheless, excessive risk reduction may come at the
expense of an optimal stone-free rate, and clearly a balance
must be struck between more aggressive stone clearance,
thereby reducing the need for future interventions an opti-
mizing renal function, and excessive caution in managing
patients with solitary kidneys. Patients with solitary kidneys,
particularly those with more impaired renal function, should
be treated as any other patients.7 The findings of recent
studies in which stone-free rates of 93.7% can be attained and
in which outcomes and complication rates after PCNL were
comparable in identically treated solitary kidney patients and
appropriately matched controls suggests that just such a
balance can be struck.3,7,19
This study was limited by several factors: First, the data
obtained were not homogenous because the centers had dif-
ferent methods to assess stone-free rates and operative times.
This may potentially have resulted in lack of a unified reporting
of outcomes. Furthermore, the biochemical makeup of the
stones was not captured in the database. This limited our ability
to compare outcomes based on the chemical compositions of
the stones treated in the two groups. Finally, the database did
not fully capture the cause of the solitary kidney status.
Conclusion
A higher cardiovascular risk and ASA score were seen in
patients with a solitary kidney. Outcomes that were related to
morbidity and stone-free rate were less favorable for patients
with solitary kidneys.
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Editorial Comment for Bucuras et al.
Nicole. L. Miller, M.D.
The primary objective of any research study is to answersome important question. As researchers, we are com-
monly limited to reporting on our own experience, but
haven’t we all wished for more? More patients, more centers,
just plain more data with the hope that the old saying, ‘‘There
is power in numbers’’ rings true and provides us with the
answers we have been seeking. This is the foundation on
which the Clinical Research Office of the Endourological
Society (CROES) was created. The CROES initiative ‘‘aims
to promote and support high quality international patient-
centered research in a transparent way and to facilitate the
implementation of research projects by creating a global net-
work.’’1 The CROES mission relies on worldwide collabora-
tion and its stated vision is clear: ‘‘To apply rigorous scientific
evaluation to the field of endourology with the intent to bring
patients globally the most effective and efficient care possi-
ble.’’ The CROES Percutaneous Nephrolithotomy (PCNL)
study was the first to test the feasibility of a project this am-
bitious. It is as a part of this larger PCNL study that this report
on patients with solitary kidneys was conducted.
While there is no question that the efforts of the CROES
PCNL study group should be applauded, there are inherent
challenges to a project of this magnitude that can impact
the conclusions gathered from the data. I think we can
categorize these strengths and limitations into those that
relate to study size and those that result from study design.
CROES data are collected in a prospective manner through
a remote data management system (DMS). The CROES
PCNL study collects data from 96 centers in 26 countries
and includes 5803 patients. The power of a study this size is
immediately evident when you consider the clinical entity
described in this article. Solitary kidney is uncommon en-
ough that single institutions would be limited to small
numbers of patients and be hard-pressed to draw any sig-
nificant conclusions, but the CROES PCNL Global study
includes 189 patients worldwide. In fact, this article sug-
gests that outcomes related to morbidity and stone-free rate
were less favorable for the solitary kidneys. The logisti-
cal challenge of collecting data from nearly 100 separate
centers, however, makes it such that CROES is reliant on
self-reporting and data entry into the DMS. This type of
self-reported data can impact the quality of the data gath-
ered by introducing the potential for missing key data
points, unreliable data, infrequent data entry, etc. Fur-
thermore, some countries have stricter Institutional Review
Board (IRB) regulations than others; therefore, the ability
to include all cases in a prospective manner for 1 year will
be different in each center, because the centers that require
IRB approval and patient consent for inclusion will be un-
likely to have every patient consent to participate. Items
that are even more difficult to control include the hetero-
geneity of the surgical selection, the approach, and the
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